Opportunities in the pharmaceutical and biotech sectors include adopting Digital CMC to streamline processes, enhance regulatory compliance, and accelerate time-to-market. Embracing Pharma 4.0 through ...
F rom blockbuster drugs that garner media attention to smaller innovations that help millions maintain health, the biotech and pharmaceutical industries have an impact on everyone’s life. Meanwhile, ...
Richard Jaenisch and Christopher Cole discuss AI in pharma manufacturing, covering learning steps, output evaluation, hallucinations, and FDA/EMA guiding principles.
Issued on behalf of Avaí Bio, Inc. VANCOUVER, BC, March 27, 2026 /PRNewswire/ -- USANewsGroup.com News Commentary — The global cell therapy manufacturing market is hitting a pivotal inflection point.
The Bio/Pharmaceutical Outsourcing Report highlights opportunities in strategic planning for CMO executives, insights for bio/pharma sourcing executives, and investment targets for investors. Key ...
As sustainability becomes a core focus for biotech, there is a growing need for professionals who can implement eco-friendly practices in biomanufacturing while ensuring regulatory compliance. This ...
College and community leaders recently smashed walls — ceremonially — at an event celebrating the start of renovation for a facility that will prepare students for highly-skilled biotechnology ...
Ryan Murray, ValSource, breaks down far UVC technology, holistic contamination control strategies, and environmental monitoring in pharma manufacturing.
DUBLIN--(BUSINESS WIRE)--The "Manufacturing and Supply Deals in Pharmaceuticals and Biotechnology 2020-2025" has been added to ResearchAndMarkets.com's offering. This report contains a comprehensive ...
DUBLIN, June 24, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (TRIB), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable ...
VILNIUS, LT / ACCESS Newswire / July 29, 2025 / Diorasis Therapeutics (“DTx”), a preclinical-stage biotechnology company developing gene therapies for ophthalmic diseases, has entered into a strategic ...
EVERETT — Sana Biotechnology has canceled plans to build a major biotech manufacturing factory in Bothell that was supposed to employ hundreds of workers within a few years. The publicly traded ...